ProShares Ultra CRCL (CRCA) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CRCA. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to CRCA
CRCA charges 0.95% annually. There are 100 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| WisdomTree Efficient U.S. Plus International Equit... | 0.35% | 44.22M | Mar 2026 | CRCA vs NTSD | |
| ETRACS IFED Invest with the Fed TR Index ETN | 0.45% | 49.31M | Sep 2021 | CRCA vs IFED | |
| Direxion Daily S&P 500 Bull 2X ETF | 0.60% | 257.66M | May 2014 | CRCA vs SPUU | |
| Leverage Shares 2X Long BIDU Daily ETF | 0.75% | — | Dec 2025 | CRCA vs BIDG | |
| Leverage Shares 2X Long ALB Daily ETF | 0.75% | — | Jan 2026 | CRCA vs ALBG |
Best Risk-Adjusted Alternatives to CRCA
Among 267 ETFs in the Leveraged Equities category with risk / return rank data, the top risk-adjusted alternatives shown here go as high as 99.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| Direxion Daily MU Bull 2X Shares | 99 | 6.16B | Oct 2024 | CRCA vs MUU | |
| GraniteShares 2x Long MU Daily ETF | 98 | 923.53M | Nov 2024 | CRCA vs MULL | |
| Innovator U.S. Equity Accelerated Plus ETF | 98 | 22.82M | Apr 2021 | CRCA vs XTAP | |
| Innovator Growth Accelerated Plus ETF - April | 97 | 20.50M | Apr 2021 | CRCA vs QTAP | |
| GraniteShares 2x Long INTC Daily ETF | 96 | 509.42M | Feb 2025 | CRCA vs INTW |
Top Performing CRCA Alternatives (YTD)
CRCA is at -68.22% YTD. There are 346 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 738.32%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| GraniteShares 2x Long DELL Daily ETF | 738.32% | 162.40M | Feb 2025 | CRCA vs DLLL | |
| Direxion Daily MU Bull 2X Shares | 575.80% | 6.16B | Oct 2024 | CRCA vs MUU | |
| GraniteShares 2x Long MU Daily ETF | 555.59% | 923.53M | Nov 2024 | CRCA vs MULL | |
| Direxion Daily INTC Bull 2X Shares | 395.01% | 101.49M | Nov 2025 | CRCA vs LINT | |
| GraniteShares 2x Long INTC Daily ETF | 394.65% | 509.42M | Feb 2025 | CRCA vs INTW |
Lowest Volatility Alternatives to CRCA
CRCA has 195.27% 1-year volatility. There are 399 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.77%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Innovator U.S. Equity Accelerated Plus ETF | 4.77% | 22.82M | Apr 2021 | CRCA vs XTAP | |
| Innovator Growth Accelerated Plus ETF - April | 6.21% | 20.50M | Apr 2021 | CRCA vs QTAP | |
| Innovator U.S. Equity Accelerated Plus ETF - July | 7.40% | 13.45M | Jul 2021 | CRCA vs XTJL | |
| Innovator Growth Accelerated Plus ETF - July | 10.50% | 20.95M | Jul 2021 | CRCA vs QTJL | |
| Innovator US Equity Accelerated ETF | 10.55% | 69.49M | Apr 2021 | CRCA vs XDSQ |
Lowest Drawdown Alternatives to CRCA
Among 267 ETFs in the Leveraged Equities category with 1-year drawdown data, the lowest-drawdown alternatives shown here go as shallow as -1.72%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Innovator U.S. Equity Accelerated Plus ETF | -1.72% | 22.82M | Apr 2021 | CRCA vs XTAP | |
| Innovator Growth Accelerated Plus ETF - April | -2.49% | 20.50M | Apr 2021 | CRCA vs QTAP | |
| Innovator U.S. Equity Accelerated Plus ETF - July | -5.12% | 13.45M | Jul 2021 | CRCA vs XTJL | |
| Innovator Growth Accelerated Plus ETF - July | -6.68% | 20.95M | Jul 2021 | CRCA vs QTJL | |
| Innovator US Equity Accelerated ETF | -9.60% | 69.49M | Apr 2021 | CRCA vs XDSQ |
Other ETFs from ProShares
The 10 most viewed ProShares ETFs shown here include TQQQ, QLD, BITO and span 10 categories. AUM among these funds goes as high as $37B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| ProShares UltraPro QQQ | Leveraged Equities | 48 | 38.33% | 37.04B | Feb 2010 | CRCA vs TQQQ | |
| ProShares Ultra QQQ | Leveraged Equities | 50 | 28.12% | 14.15B | Jun 2006 | CRCA vs QLD | |
| ProShares Bitcoin Strategy ETF | Cryptocurrency | 1 | -30.09% | 1.45B | Oct 2021 | CRCA vs BITO | |
| ProShares UltraPro S&P 500 | Leveraged Equities, S&P 500 | 52 | 23.85% | 5.47B | Jun 2009 | CRCA vs UPRO | |
| ProShares Ultra S&P500 | Leveraged Equities, S&P 500 | 54 | 17.32% | 8.13B | Jun 2006 | CRCA vs SSO | |
| ProShares Ultra Semiconductors | Leveraged Equities, Semiconductors | 70 | 70.32% | 2.97B | Jan 2007 | CRCA vs USD | |
| ProShares S&P 500 Dividend Aristocrats ETF | Dividend, S&P 500, Large Cap Value Equities | 37 | 10.60% | 11.63B | Oct 2013 | CRCA vs NOBL | |
| ProShares UltraPro Short QQQ | Leveraged Equities, Inverse Equities, Nasdaq-100 | 1 | -40.27% | 2.09B | Feb 2010 | CRCA vs SQQQ | |
| ProShares Nasdaq-100 High Income ETF | Nasdaq-100, Derivative Income, Dividend | 54 | 13.67% | 410.75M | Mar 2024 | CRCA vs IQQQ | |
| ProShares Ultra VIX Short-Term Futures ETF | Volatility | 2 | -32.31% | 216.19M | Oct 2011 | CRCA vs UVXY |
Often Compared With CRCA
Investors most often compare CRCA with DFNM, BITU, NVDG. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.
Compare CRCA with Any Fund or Stock
Compare CRCA with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair CRCA with funds that move differently
ProShares Ultra CRCL alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to CRCA.
Explore CRCA Diversifiers